ID CLD16_HUMAN Reviewed; 235 AA. AC Q9Y5I7; DT 30-MAY-2000, integrated into UniProtKB/Swiss-Prot. DT 23-FEB-2022, sequence version 2. DT 24-JAN-2024, entry version 182. DE RecName: Full=Claudin-16; DE AltName: Full=Paracellin-1; DE Short=PCLN-1; GN Name=CLDN16; Synonyms=PCLN1; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS HOMG3 PRO-97; ARG-121; ASP-128; RP CYS-162; ASP-163; PHE-165 AND ARG-169. RX PubMed=10390358; DOI=10.1126/science.285.5424.103; RA Simon D.B., Lu Y., Choate K.A., Velazquez H., Al-Sabban E., Praga M., RA Casari G., Bettinelli A., Colussi G., Rodriguez-Soriano J., McCredie D., RA Milford D., Sanjad S., Lifton R.P.; RT "Paracellin-1, a renal tight junction protein required for paracellular RT Mg2+ resorption."; RL Science 285:103-106(1999). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [3] RP VARIANTS HOMG3 ASP-71; PRO-75; PHE-81; PRO-81; TRP-81; ASP-128 AND ARG-169. RX PubMed=10878661; DOI=10.1038/sj.ejhg.5200475; RA Weber S., Hoffmann K., Jeck N., Saar K., Boeswald M., Kuwertz-Broeking E., RA Meij I.I., Knoers N.V., Cochat P., Sulakova T., Bonzel K.E., Soergel M., RA Manz F., Schaerer K., Seyberth H.W., Reis A., Konrad M.; RT "Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis maps to RT chromosome 3q27 and is associated with mutations in the PCLN-1 gene."; RL Eur. J. Hum. Genet. 8:414-422(2000). RN [4] RP VARIANTS HOMG3 ASP-71; PRO-75; LEU-79; PHE-81; TRP-81; ALA-128; THR-139; RP THR-146; PRO-165 AND ARG-169. RX PubMed=11518780; DOI=10.1681/asn.v1291872; RA Weber S., Schneider L., Peters M., Misselwitz J., Roennefarth G., RA Boeswald M., Bonzel K.E., Seeman T., Sulakova T., Kuwertz-Broeking E., RA Gregoric A., Palcoux J.-B., Tasic V., Manz F., Schaerer K., Seyberth H.W., RA Konrad M.; RT "Novel paracellin-1 mutations in 25 families with familial hypomagnesemia RT with hypercalciuria and nephrocalcinosis."; RL J. Am. Soc. Nephrol. 12:1872-1881(2001). CC -!- FUNCTION: Plays a major role in tight junction-specific obliteration of CC the intercellular space, through calcium-independent cell-adhesion CC activity. Involved in paracellular magnesium reabsorption. Required for CC a selective paracellular conductance. May form, alone or in partnership CC with other constituents, an intercellular pore permitting paracellular CC passage of magnesium and calcium ions down their electrochemical CC gradients. Alternatively, it could be a sensor of magnesium CC concentration that could alter paracellular permeability mediated by CC other factors. CC -!- INTERACTION: CC Q9Y5I7; Q9Z0S3: Cldn14; Xeno; NbExp=3; IntAct=EBI-7774981, EBI-7774956; CC -!- SUBCELLULAR LOCATION: Cell junction, tight junction. Cell membrane; CC Multi-pass membrane protein. CC -!- TISSUE SPECIFICITY: Kidney-specific, including the thick ascending limb CC of Henle (TAL). CC -!- DISEASE: Hypomagnesemia 3 (HOMG3) [MIM:248250]: A progressive renal CC disease characterized by primary renal magnesium wasting with CC hypomagnesemia, hypercalciuria and nephrocalcinosis. Recurrent urinary CC tract infections and kidney stones are often observed. In spite of CC hypercalciuria, patients do not show hypocalcemia. CC {ECO:0000269|PubMed:10390358, ECO:0000269|PubMed:10878661, CC ECO:0000269|PubMed:11518780}. Note=The disease is caused by variants CC affecting the gene represented in this entry. CC -!- SIMILARITY: Belongs to the claudin family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF152101; AAD43096.1; -; mRNA. DR EMBL; BC069662; AAH69662.1; -; mRNA. DR EMBL; BC069682; AAH69682.1; -; mRNA. DR EMBL; BC069759; AAH69759.1; -; mRNA. DR EMBL; BC069777; AAH69777.1; -; mRNA. DR CCDS; CCDS3296.2; -. DR RefSeq; NP_006571.1; NM_006580.3. DR AlphaFoldDB; Q9Y5I7; -. DR SMR; Q9Y5I7; -. DR BioGRID; 115925; 3. DR DIP; DIP-48951N; -. DR IntAct; Q9Y5I7; 3. DR MINT; Q9Y5I7; -. DR STRING; 9606.ENSP00000264734; -. DR DrugBank; DB14513; Magnesium. DR TCDB; 1.H.1.1.1; the claudin tight junction (claudin1) family. DR iPTMnet; Q9Y5I7; -. DR PhosphoSitePlus; Q9Y5I7; -. DR BioMuta; CLDN16; -. DR DMDM; 6685318; -. DR MassIVE; Q9Y5I7; -. DR PaxDb; 9606-ENSP00000264734; -. DR PeptideAtlas; Q9Y5I7; -. DR ProteomicsDB; 86416; -. DR Antibodypedia; 19357; 219 antibodies from 25 providers. DR DNASU; 10686; -. DR Ensembl; ENST00000264734.3; ENSP00000264734.3; ENSG00000113946.4. DR GeneID; 10686; -. DR KEGG; hsa:10686; -. DR MANE-Select; ENST00000264734.3; ENSP00000264734.3; NM_006580.4; NP_006571.2. DR UCSC; uc003fsi.3; human. DR AGR; HGNC:2037; -. DR CTD; 10686; -. DR DisGeNET; 10686; -. DR GeneCards; CLDN16; -. DR HGNC; HGNC:2037; CLDN16. DR HPA; ENSG00000113946; Tissue enriched (kidney). DR MalaCards; CLDN16; -. DR MIM; 248250; phenotype. DR MIM; 603959; gene. DR neXtProt; NX_Q9Y5I7; -. DR OpenTargets; ENSG00000113946; -. DR Orphanet; 31043; Primary hypomagnesemia with hypercalciuria and nephrocalcinosis without severe ocular involvement. DR PharmGKB; PA26563; -. DR VEuPathDB; HostDB:ENSG00000113946; -. DR eggNOG; ENOG502QRY9; Eukaryota. DR GeneTree; ENSGT00730000111162; -. DR HOGENOM; CLU_079378_0_0_1; -. DR InParanoid; Q9Y5I7; -. DR OMA; GLHCVKF; -. DR PhylomeDB; Q9Y5I7; -. DR TreeFam; TF331936; -. DR PathwayCommons; Q9Y5I7; -. DR Reactome; R-HSA-420029; Tight junction interactions. DR SignaLink; Q9Y5I7; -. DR BioGRID-ORCS; 10686; 5 hits in 1135 CRISPR screens. DR ChiTaRS; CLDN16; human. DR GeneWiki; CLDN16; -. DR GenomeRNAi; 10686; -. DR Pharos; Q9Y5I7; Tbio. DR PRO; PR:Q9Y5I7; -. DR Proteomes; UP000005640; Chromosome 3. DR RNAct; Q9Y5I7; Protein. DR Bgee; ENSG00000113946; Expressed in male germ line stem cell (sensu Vertebrata) in testis and 81 other cell types or tissues. DR ExpressionAtlas; Q9Y5I7; baseline and differential. DR GO; GO:0005923; C:bicellular tight junction; ISS:UniProtKB. DR GO; GO:0005886; C:plasma membrane; IBA:GO_Central. DR GO; GO:0042802; F:identical protein binding; ISS:UniProtKB. DR GO; GO:0015095; F:magnesium ion transmembrane transporter activity; TAS:ProtInc. DR GO; GO:0005198; F:structural molecule activity; IEA:InterPro. DR GO; GO:0070830; P:bicellular tight junction assembly; IBA:GO_Central. DR GO; GO:0016338; P:calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules; ISS:UniProtKB. DR GO; GO:0007155; P:cell adhesion; IBA:GO_Central. DR GO; GO:0010496; P:intercellular transport; TAS:ProtInc. DR GO; GO:0030003; P:intracellular monoatomic cation homeostasis; TAS:ProtInc. DR GO; GO:0030001; P:metal ion transport; TAS:UniProtKB. DR Gene3D; 1.20.140.150; -; 1. DR InterPro; IPR006187; Claudin. DR InterPro; IPR003927; Claudin16. DR InterPro; IPR017974; Claudin_CS. DR InterPro; IPR004031; PMP22/EMP/MP20/Claudin. DR PANTHER; PTHR12002; CLAUDIN; 1. DR PANTHER; PTHR12002:SF56; CLAUDIN-16; 1. DR Pfam; PF00822; PMP22_Claudin; 1. DR PRINTS; PR01077; CLAUDIN. DR PRINTS; PR01447; CLAUDIN16. DR PROSITE; PS01346; CLAUDIN; 1. DR Genevisible; Q9Y5I7; HS. PE 1: Evidence at protein level; KW Cell junction; Cell membrane; Disease variant; Ion transport; Magnesium; KW Membrane; Primary hypomagnesemia; Reference proteome; Tight junction; KW Transmembrane; Transmembrane helix; Transport. FT CHAIN 1..235 FT /note="Claudin-16" FT /id="PRO_0000144774" FT TOPO_DOM 1..3 FT /note="Cytoplasmic" FT /evidence="ECO:0000305" FT TRANSMEM 4..24 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 25..79 FT /note="Extracellular" FT /evidence="ECO:0000305" FT TRANSMEM 80..100 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 101..115 FT /note="Cytoplasmic" FT /evidence="ECO:0000305" FT TRANSMEM 116..136 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 137..169 FT /note="Extracellular" FT /evidence="ECO:0000305" FT TRANSMEM 170..190 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 191..235 FT /note="Cytoplasmic" FT /evidence="ECO:0000305" FT VARIANT 71 FT /note="H -> D (in HOMG3)" FT /evidence="ECO:0000269|PubMed:10878661, FT ECO:0000269|PubMed:11518780" FT /id="VAR_017228" FT VARIANT 75 FT /note="L -> P (in HOMG3; dbSNP:rs104893731)" FT /evidence="ECO:0000269|PubMed:10878661, FT ECO:0000269|PubMed:11518780" FT /id="VAR_017229" FT VARIANT 79 FT /note="R -> L (in HOMG3; dbSNP:rs968906940)" FT /evidence="ECO:0000269|PubMed:11518780" FT /id="VAR_017230" FT VARIANT 81 FT /note="L -> F (in HOMG3; dbSNP:rs104893729)" FT /evidence="ECO:0000269|PubMed:10878661, FT ECO:0000269|PubMed:11518780" FT /id="VAR_017231" FT VARIANT 81 FT /note="L -> P (in HOMG3)" FT /evidence="ECO:0000269|PubMed:10878661" FT /id="VAR_017232" FT VARIANT 81 FT /note="L -> W (in HOMG3; dbSNP:rs104893730)" FT /evidence="ECO:0000269|PubMed:10878661, FT ECO:0000269|PubMed:11518780" FT /id="VAR_017233" FT VARIANT 97 FT /note="L -> P (in HOMG3; dbSNP:rs104893725)" FT /evidence="ECO:0000269|PubMed:10390358" FT /id="VAR_008174" FT VARIANT 121 FT /note="G -> R (in HOMG3; dbSNP:rs104893722)" FT /evidence="ECO:0000269|PubMed:10390358" FT /id="VAR_008175" FT VARIANT 128 FT /note="G -> A (in HOMG3)" FT /evidence="ECO:0000269|PubMed:11518780" FT /id="VAR_017234" FT VARIANT 128 FT /note="G -> D (in HOMG3; dbSNP:rs104893723)" FT /evidence="ECO:0000269|PubMed:10390358, FT ECO:0000269|PubMed:10878661" FT /id="VAR_008176" FT VARIANT 139 FT /note="A -> T (in HOMG3; dbSNP:rs1270704258)" FT /evidence="ECO:0000269|PubMed:11518780" FT /id="VAR_017235" FT VARIANT 146 FT /note="R -> T (in HOMG3)" FT /evidence="ECO:0000269|PubMed:11518780" FT /id="VAR_017236" FT VARIANT 162 FT /note="F -> C (in HOMG3; dbSNP:rs104893726)" FT /evidence="ECO:0000269|PubMed:10390358" FT /id="VAR_008177" FT VARIANT 163 FT /note="G -> D (in HOMG3; dbSNP:rs104893727)" FT /evidence="ECO:0000269|PubMed:10390358" FT /id="VAR_008178" FT VARIANT 165 FT /note="S -> F (in HOMG3; dbSNP:rs104893728)" FT /evidence="ECO:0000269|PubMed:10390358" FT /id="VAR_008179" FT VARIANT 165 FT /note="S -> P (in HOMG3)" FT /evidence="ECO:0000269|PubMed:11518780" FT /id="VAR_017237" FT VARIANT 169 FT /note="G -> R (in HOMG3; dbSNP:rs104893721)" FT /evidence="ECO:0000269|PubMed:10390358, FT ECO:0000269|PubMed:10878661, ECO:0000269|PubMed:11518780" FT /id="VAR_008172" SQ SEQUENCE 235 AA; 26078 MW; 258633C2920B8807 CRC64; MRDLLQYIAC FFAFFSAGFL IVATWTDCWM VNADDSLEVS TKCRGLWWEC VTNAFDGIRT CDEYDSILAE HPLKLVVTRA LMITADILAG FGFLTLLLGL DCVKFLPDEP YIKVRICFVA GATLLIAGTP GIIGSVWYAV DVYVERSTLV LHNIFLGIQY KFGWSCWLGM AGSLGCFLAG AVLTCCLYLF KDVGPERNYP YSLRKAYSAA GVSMAKSYSA PRTETAKMYA VDTRV //